武汉云克隆科技股份有限公司

异柠檬酸脱氢酶1(IDH1)单克隆抗体

Monoclonal Antibody to Isocitrate Dehydrogenase 1, Soluble (IDH1)

PICD; IDP; Oxalosuccinate decarboxylase; NADP(+)-specific ICDH; Cytosolic NADP-isocitrate dehydrogenase

  • 异柠檬酸脱氢酶1(IDH1)单克隆抗体产品包装(模拟)
  • 异柠檬酸脱氢酶1(IDH1)单克隆抗体产品包装(模拟)
  • 异柠檬酸脱氢酶1(IDH1)单克隆抗体DAB staining on IHC-P; Samples: Human Prostate Tissue; Primary Ab: 30µg/ml Mouse Anti-Human IDH1 Antibody Second Ab: 2µg/mL HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody (Catalog: SAA544Mu19)
  • 异柠檬酸脱氢酶1(IDH1)单克隆抗体Vector Red staining on IHC-P;
    Samples: Human Prostate Tissue;
    Primary Ab: 10µg/ml Mouse Anti-Human IDH1 Antibody
    Second Ab: 2µg/mL HRP-Linked Caprine Anti-Mouse IgG Monoclonal Antibody
  • MAH839Hu21.jpgFigure. Western Blot; Sample: Recombinant IDH1, Human.
  • 异柠檬酸脱氢酶1(IDH1)单克隆抗体Western Blot; Sample: Porcine Liver lysate;
    Primary Ab: 5µg/ml Mouse Anti-Human IDH1 Antibody
    Second Ab: 0.2µg/mL HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
    (Catalog: SAA544Mu19)
  • Certificate通过ISO 9001、ISO 13485质量体系认证

特异性

该抗体是针对IDH1的小鼠单克隆抗体。在免疫组织化学染色和免疫印迹实验中能识别IDH1。

用法

Western blotting: 0.01-5µg/mL;
Immunohistochemistry: 5-30µg/mL;
Immunocytochemistry: 5-20µg/mL;
Optimal working dilutions must be determined by end user.

储存

经常使用则4°C保存。-20°C保存不超过两年。避免反复冻融。

稳定性

热稳定性以损失率显示。损失率是由加速降解试验决定，具体方法如下：在37°C孵育48小时，没有显著的降解或者沉淀产生。保质期内，在适当的条件下存储，损失率低于5%。

赠品

相关产品

编号适用物种：Homo sapiens (Human，人)应用(仅供研究使用，不用于临床诊断！)
RPH839Hu01异柠檬酸脱氢酶1(IDH1)重组蛋白Positive Control; Immunogen; SDS-PAGE; WB.
PAH839Hu01异柠檬酸脱氢酶1(IDH1)多克隆抗体WB,IHC,ICC/IF
FAH839Hu01抗异柠檬酸脱氢酶1(IDH1)多克隆抗体Flow cytometry.
MAH839Hu22异柠檬酸脱氢酶1(IDH1)单克隆抗体WB; IHC
MAH839Hu23异柠檬酸脱氢酶1(IDH1)单克隆抗体WB; IHC; ICC; IP.
MAH839Hu25异柠檬酸脱氢酶1(IDH1)单克隆抗体WB; IHC; ICC; IP.
MAH839Hu27异柠檬酸脱氢酶1(IDH1)单克隆抗体WB; IHC; ICC; IP.
MAH839Hu29异柠檬酸脱氢酶1(IDH1)单克隆抗体WB; IHC; ICC; IP.
MAH839Hu24异柠檬酸脱氢酶1(IDH1)单克隆抗体WB; IHC
MAH839Hu26异柠檬酸脱氢酶1(IDH1)单克隆抗体WB; IHC
MAH839Hu21异柠檬酸脱氢酶1(IDH1)单克隆抗体WB; IHC; ICC; IP.
RAH839Hu21异柠檬酸脱氢酶1(IDH1)重组抗体WB; IFC; IHC; IP.
FAH839Hu02抗异柠檬酸脱氢酶1(IDH1)单克隆抗体Flow cytometry.
FAH839Hu04抗异柠檬酸脱氢酶1(IDH1)单克隆抗体Flow cytometry.
FAH839Hu06抗异柠檬酸脱氢酶1(IDH1)单克隆抗体Flow cytometry.
FAH839Hu08抗异柠檬酸脱氢酶1(IDH1)单克隆抗体Flow cytometry.
LAH839Hu76异柠檬酸脱氢酶1(IDH1)单克隆抗体(生物素标记)WB; IHC; ICC.
IEH839Hu异柠檬酸脱氢酶1(IDH1)检测试剂盒(酶联免疫吸附试验法,快捷型)Enzyme-linked immunosorbent assay for Antigen Detection.
SEH839Hu异柠檬酸脱氢酶1(IDH1)检测试剂盒(酶联免疫吸附试验法)Enzyme-linked immunosorbent assay for Antigen Detection.
SCH839Hu异柠檬酸脱氢酶1(IDH1)检测试剂盒(化学发光免疫分析法)Chemiluminescent immunoassay for Antigen Detection.
LMH839Hu异柠檬酸脱氢酶1(IDH1)等多因子检测试剂盒(流式荧光发光法)FLIA Kit for Antigen Detection.
PSH839Hu01异柠檬酸脱氢酶1(IDH1)抗体对ELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays.
KSH839Hu01异柠檬酸脱氢酶1(IDH1)检测试剂盒DIY材料(酶联免疫吸附试验法)Main materials for "Do It (ELISA Kit) Yourself".

参考文献

杂志参考文献
Molecular & Cellular ProteomicsIdentification of IDH1 as a Potential Diagnostic and Prognostic Biomarker for Non-small-cell Lung Cancer by Proteomic Analysis[Mcponline: 008821]
Molecular & Cellular ProteomicsIdentification of Isocitrate Dehydrogenase 1 as a Potential Diagnostic and Prognostic Biomarker for Non-small Cell Lung Cancer by Proteomic Analysis[Pubmed: 22064513]
Clinical Cancer ResearchIsocitrate dehydrogenase 1 is a novel plasma biomarker for the diagnosis of non-small cell lung cancer[Pubmed: 24046070]
Onco Targets TherThe effects of PGC-1α on the proliferation and energy metabolism of malignant endometrial cancer cells[PubMed: 25914546]
OncogeneMetformin sensitizes endometrial cancer cells to chemotherapy through IDH1-induced Nrf2 expression via an epigenetic mechanism[Pubmed:29921847]
Molecular OncologyIDH 2 is a novel diagnostic and prognostic serum biomarker for non‐small‐cell lung cancer[Pubmed:29465809]
CancersSerological Biomarkers for Early Detection of Hepatocellular Carcinoma: A Focus on Autoantibodies against Tumor-Associated Antigens Encoded by Cancer Driver …[Pubmed: 32443439]
International Journal of CancerProteome profiling of enzalutamide‐resistant cell lines and serum analysis identified ALCAM as marker of resistance in castration‐resistant prostate cancer[Pubmed:35689436]